Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cannabix Technologies Inc C.BLO

Alternate Symbol(s):  BLOZF

Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Company’s primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection.


CSE:BLO - Post by User

Bullboard Posts
Comment by Minitaton Jun 27, 2018 7:33pm
171 Views
Post# 28241186

RE:Malibu’s take

RE:Malibu’s take Here's my take on this.  BLO and BTH (Breathtec Biomedical) are linked with a similar basis of operation, namely a breath sample is used to determine level of cannabis use for one while a breath sample is used to detect diseases.

It could very well be that ownership is freeing up some cash to invest in BTH because of the parallel development for different purposes, and perhaps BTH has made significant progress since January 2018.  Recency of use is not a necessary criteria for a disease detector, therefore a parameter which doesn't impede its development meaning it could come to market first.  If it does, then it would only be excellent news for BLO.

https://ceo.ca/@nasdaq/breathtec-biomedical-provides-development-update-on

I'm taking a peek at BTH as it is only $0.13 and maybe, just maybe one might be a winner on 2 fronts.

DYODD and GLTA



Bullboard Posts